You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Litigation Details for Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd. (N.D. Cal. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd. (N.D. Cal. 2016)

Docket   Start Trial Date Filed 2016-05-24
Court District Court, N.D. California Date Terminated 2019-03-25
Cause 35:271 Patent Infringement Assigned To William Horsley Orrick III
Jury Demand Both Referred To Joseph Spero
Patents 6,002,008; 6,005,020; 8,039,009; 8,644,239; 9,000,011
Attorneys Alan Lee Whitehurst; Alan Lee Whitehurst ,; Benjamin Laban Singer; Brian E Mack; Carl Gunnar Anderson; Charles Kramer Verhoeven; Cole Daniel Malmberg; Cory D. Szczepanik; Cory David Szczepanik; Curt Holbreich; Daryl M. Crone; David Andrew Perlson; David Giardina; David LeRay; David T. Pritikin; Deepa Acharya; Douglas I. Lewis; Ellen S. Robbins; Evan N. Budaj; Iman Lordgooei; Irene Inkyu Yang; Jared Weston Newton; Jocelyn Ma; John P. Wisse; John Weatherby McBride; Kevin Hardy; Kevin Joseph O'Brien; Kevin P.B. Johnson; Leif E. Peterson , II; Marissa R. Ducca; Marissa R. Ducca ,; Mark Thomas Gray; Melissa J Baily; Michael J. Bettinger; Nathan A. Greenblatt; Nathaniel C. Love; Philip Charles Sternhell; Rachel R. Davidson; Rafik Paul Zeineddin; Raquel Catalina Rodriguez; Ray R. Zado; Russell E. Cass; Ryan W. Koppelman; Sam Stephen Stake; Samuel Bryant Davidoff; Theresa H Nguyen; Thomas D. Pease; Victoria F. Maroulis
Firms Akerman LLP; Alston & Bird LLP; Crone Hawxhurst LLP; Jared Weston Newton; Kevin Hardy; Perkins Coie LLP; Quinn Emanuel; Quinn Emanuel Urquhart & Sullian LLP; Quinn Emanuel Urquhart & Sullivan; Quinn Emanuel Urquhart & Sullivan LLP; Quinn Emanuel Urquhart & Sullivan, LLP; Quinn Emanuel Urquhart and Sullivan LLP; Quinn Emanuel Urquhart Oliver & Hedges L; Quinn Emmanuel Urquhart & Sullivan LLP; Quinn Emmanuel Urquhart & Sullivan LP; Sidley Austin LLP; Sidley Austin, LLP; Singer Bea LLP; Williams & Connolly LLP; Zeineddin PLLC
Link to Docket External link to docket
Small Molecule Drugs cited in Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd. (N.D. Cal. 2016)

Date Filed Document No. Description Snippet Link To Document
2017-08-31 168 Order 166 patent”); 8,812,848; 8,644,239 (“the ’239 patent”); 8,885,587; 8,885,583; 8,639,246…27 ’246 patent”); 8,412,197 (“the ’197 patent”); 8,996,003; and 8,724,613 (“the ’613 patent”). …26 Huawei has asserted U.S. Patent Nos. 8,369,278 (“the ’278 patent”); 8,416,892; 8,483,166 (“the …Samsung has asserted U.S. Patent Nos. 8,228,827, 8,315,195 (“the ’195 patent”), RE44,105, …8,457,588 (“the ’588 patent”), 8,509,350, 9,113,419, 8,619,726 (“the ’726 patent”), 8,761,130 External link to document
2017-10-03 191 Writ Issued U.S. Patent Nos. 8,369,278; 8,416,892; 8,483,166; 8,812,848; 8,644,239; 8,885,587; 8,885,583; 8,639,246;…standard-essential patents (“SEPS”). In addition, Huawei alleged that Samsung infringes eleven of its patents: U.S.…alleged that Huawei infringes nine of its patents: U.S. Patent Nos. 8,228,827; 8,315,195; RE44,105; 8,…that they infringe the patents asserted against them and contend that the patents asserted against them…art exists that anticipates the patented claims or renders the patented claims obvious. Huawei has alleged External link to document
2018-01-30 231 Transcript 25, S8 [5] - 4:9, 4:14, 7:1 12:13, 14:6 5:20, 6:16, 7:18, 8:14, 11:10 S8+ [1] - 4…reasons -- 7 THE COURT: Only in a patent case could somebody say 8 in January the trial…mean, typically the guidance in the 3 local patent rules, which is if there's good cause and if… So we just need to understand because the patents go both 6 ways. 7 THE COURT: …decision two weeks ago in 2 China on belated patents. The Court in China ruled on the 3 infringement External link to document
2018-06-26 318 Huawei's Updated Election of Asserted Claims and Accused Products (REDACTE • U.S. Patent 8,416,892, claims 1, 10 9 • U.S. Patent 8,644,239, claims 7, 18 10…currently asserted 5 patents to 4, narrows its currently asserted patent claims to no more than 10…10 • U.S. Patent 8,885,587, claims 3, 9 11 • U.S. Patent 8,724,613, claims 1, 5 12…purposes of assessing 17 infringement of Huawei’s patents. Therefore, provided that the parties enter or …2016 25 March 2019 3:16-cv-02787 830 Patent Both District Court, N.D. California External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.